Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

14
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
14
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

255
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
255
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

463
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
463
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

134
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
134
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

473
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
473

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postprandial Triglycerides and Residual Cardiovascular Risk: Rethinking Lipid-Lowering Strategies.

Current vascular pharmacology·2026
Same author

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Impact of postoperative hydrocortisone replacement dose on health-related quality of life and metabolic parameters in patients with cured Cushing's syndrome: randomized, open-label, controlled trial.

Endocrine·2026
Same author

Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026
Same author

Thyroid hormone resistance beta and autoimmune thyroid disease - a family case study highlighting diagnostic and therapeutic challenges.

Cardiovascular diabetology. Endocrinology reports·2026
Same author

Letter: Integrating Noninvasive Liver Indices into Risk Stratification of Myocardial Infarction With Non-Obstructive Coronary Arteries.

Angiology·2026

Related Experiment Video

Updated: May 9, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.5K

Hypopituitarism and Cardiovascular Risk.

Ivana Kraljević1,2, Mirsala Solak2, Ante Mandić3,4

  • 1School of Medicine, University of Zagreb, Zagreb, Croatia.

Journal of Cardiovascular Pharmacology and Therapeutics
|April 30, 2025
PubMed
Summary

Hypopituitarism increases cardiovascular risk due to hormone deficiencies and metabolic issues. Optimizing hormone replacement therapy (HRT) may reduce this risk and improve patient outcomes.

Keywords:
GH deficiencycardiovascular diseasecardiovascular riskhormone replacement therapyhypopituitarism

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.3K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.8K

Related Experiment Videos

Last Updated: May 9, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.5K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.3K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.8K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Hypopituitarism, a deficiency in pituitary hormones, is linked to higher cardiovascular (CV) morbidity and mortality.
  • It causes metabolic dysregulation (insulin resistance, dyslipidemia, visceral adiposity) and inflammation, increasing CV disease (CVD) risk.
  • Standard hormone replacement therapy (HRT) can have adverse metabolic effects, potentially worsening atherosclerosis.

Purpose of the Study:

  • To review the causes and CV risk mechanisms in hypopituitarism.
  • To analyze treatment strategies for mitigating CV morbidity and mortality.

Main Methods:

  • Comprehensive literature review focusing on etiology, pathophysiology, and treatment of CV risk in hypopituitarism.

Main Results:

  • Hypopituitarism leads to multiple endocrine deficits, promoting metabolic syndrome and CVD.
  • Chronic inflammation and endothelial dysfunction are key contributors to elevated CV risk.
  • Optimizing HRT, particularly for growth hormone and cortisol, shows promise in reducing CV risks.

Conclusions:

  • Hypopituitarism significantly elevates cardiovascular risk through complex pathophysiological pathways.
  • Tailored hormone replacement therapy and management of metabolic factors are essential for improving CV outcomes.